MeVis Medical Solutions AGFRA:M3V 66 Net Current Asset Value is €0.72 as of Mar. 2026, which is 100% below its 10-year median of 45.27. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.72. The stock has 5 warning signs investors should review. Among 273 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks worse than 90.11% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
MeVis Medical Solutions AG's net current asset value per share for the quarter that ended in Mar. 2026 was €0.72.
The historical rank and industry rank for MeVis Medical Solutions AG's Net Current Asset Value or its related term are showing as below:
FRA:M3V'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 2.67 Med: 45.27 Max: 63.7
Current: 33.8
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of MeVis Medical Solutions AG was 63.70. The lowest was 2.67. And the median was 45.27.
FRA:M3V's Price-to-Net-Current-Asset-Value is ranked worse than 90.11% of 273
companies
in the Healthcare Providers & Services industry
Industry Median: 6
vs FRA:M3V: 33.80
MeVis Medical Solutions AG (FRA:M3V) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
MeVis Medical Solutions AG Net Current Asset Value Related Terms
MeVis Medical Solutions AG Net Current Asset Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG Net Current Asset Value Chart
FRA:M3V vs VEEV, BTSG, TEM: Net Current Asset Value Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of €0.72 mean?
MeVis Medical Solutions AG (FRA:M3V) has a Net Current Asset Value of €0.72 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MeVis Medical Solutions AG and its competitors. This is 98% below median its historical median of 45.27. Over the past decade, MeVis Medical Solutions AG's Net Current Asset Value has ranged from 2.67 to 63.70. According to the industry distribution chart, MeVis Medical Solutions AG ranks #246 out of 273 companies in the Healthcare Providers & Services industry, placing it in the top 90.1%.
Is MeVis Medical Solutions AG's Net Current Asset Value too high?
MeVis Medical Solutions AG's current Net Current Asset Value of €0.72 is 98% below median its 10-year median of 45.27. Over the past 10 years, this metric has ranged from a low of 2.67 to a high of 63.70. Based on the distribution chart, MeVis Medical Solutions AG ranks #246 out of 273 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Net Current Asset Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #246 out of 273 companies for Net Current Asset Value. This places MeVis Medical Solutions AG in the lower half of its industry. The industry median Net Current Asset Value is 6.00. Historically, MeVis Medical Solutions AG's own Net Current Asset Value has ranged from 2.67 to 63.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.00, based on 273 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Net Current Asset Value is €0.72, which is 98% below median its own 10-year median of 45.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Net Current Asset Value of €0.72. The stock's GF Value™ is €22.72, compared to a current price of €24.00 — trading 5.6% above its estimated fair value. The current Net Current Asset Value is €0.72, which is 98% below median its 10-year median of 45.27. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Net Current Asset Value is €0.72 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €24.00 is trading 5.6% above its estimated GF Value™ of €22.72.
Key valuation signals for FRA:M3V:
Net Current Asset Value: €0.72 (98% below median its 10-year median of 45.27)
GF Value™: €22.72 vs. price of €24.00 (5.6% above fair value)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
